As jockeying in the opioid litigation continues, a U.S. appeals court ruled several large pharmacy chains will not have to face allegations in so-called bellwether cases that they contributed to the opioid crisis by dispensing the addictive painkillers.

The ruling is a victory for such retailers as CVS (CVS), Walgreens (WBA), and Rite-Aid (RAD), which had argued that a federal district court incorrectly allowed two Ohio counties to pass a deadline and pursue the accusations. As a result, the pharmacies potentially face less liability. A bellwether case, by the way, is a trial that tests different arguments in order to move litigation forward.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy